Publications
- Missed bleeding events after ticagrelor in PEGASUS trial: Massive non-compliance, information censoring, or both?2016 | Second Faculty of Medicine
- Inferiority of ticagrelor in the PHILO trial: Play of chance in East Asians or nightmare confirmation of PLATO-USA?2016 | Second Faculty of Medicine
- Central nervous system vasculitis2015 | Second Faculty of Medicine
- The Bleeding Risk during Warfarin Therapy Is Associated with the Number of Variant Alleles of CYP2C9 and VKORC1 Genes2013 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport, Faculty of Medicine in Pilsen
- Accuracy of pharmacogenetic algorithms in predicting warfarin daily dose2013 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Refuting the Ticagrelor-Aspirin Black Box Warning: And Proposing a Ticagrelor Early-PCI Black Box Warning2013 | Second Faculty of Medicine
- Pharmacogenetic examination and anticoagulant treatment with warfarin2011 | Second Faculty of Medicine
- Optimization of Anticoagulation with Warfarin for Stroke Prevention: Pharmacogenetic Considerations2011 | Second Faculty of Medicine
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation2009 | Second Faculty of Medicine
- Application of warfarin pharmacogenetics2009 | Publication without faculty affiliation
Loading network view...